AT
Aditya Tolia
Private Equity Senior Analyst
OrbiMed
Private Equity Senior Analyst at OrbiMed with prior Investec and PwC banking experience.
Bio
Professional summary
David Wang is a Partner and Senior Managing Director on OrbiMed's Asia team, focused on Greater China, and joined the firm in 2011. He was previously Managing Director at WI Harper Group for healthcare investments in China and Head of Business Development at Siemens Medical Solutions. Earlier, he co-founded First Genetic Trust and held a leadership role in The SNP Consortium while at Bristol-Myers Squibb.
Notable companies
Selected portfolio companies the partner has backed
Gracell BiotechnologiesAK Medical HoldingsEdan InstrumentsLaeknaSirius Therapeutics
Background
Career, education, and skills
Career history
- OrbiMedPartner and Senior Managing Director, Asia2011 – Present
- WI Harper GroupManaging Director, Healthcare Investment2006 – 2011
- Siemens Medical SolutionsHead of Business Development
- First Genetic TrustCo-founder and EVP
Education
- Peking University Medical SchoolM.D.
- California Institute of TechnologyPh.D. in Developmental Biology
- Peking University School of MedicineBachelor's degree in Basic Medicine
Other partners at OrbiMed
12 more profiles
Alexis Megibow
Private Equity Associate
OrbiMed
Private Equity Associate at OrbiMed.
Ankesh Bhansali
Managing Director
OrbiMed
OrbiMed Asia Managing Director focused on healthcare private equity.
Arun Sadhanandham
Managing Director
OrbiMed
OrbiMed Asia Managing Director investing in healthcare private equity.
BC
Brendan Weber, CFA
Principal
OrbiMed
Principal on OrbiMed's Credit & Royalty team focused on structured credit and royalty financings.
CG
Carl Gordon
Managing Partner
OrbiMed
OrbiMed Managing Partner leading private equity and biotech company formation.
Carl L. Gordon
Managing Partner
OrbiMed
Carl L. Gordon is a Managing Partner at OrbiMed and leads the firm's private equity team.
CN
Carter Neild
Managing Partner
OrbiMed
OrbiMed Managing Partner focused on healthcare royalties and Asia private investments.
Clay Daniel DeMarcus
Principal
OrbiMed
Principal focused on medical technology and non-therapeutics venture investing.
CS
Cooper Steputis
Private Equity / Venture Capital
OrbiMed
Healthcare private equity and venture investor with prior investment banking experience.
Daniel Ying
Executive Director
OrbiMed
OrbiMed Asia Executive Director focused on pharma and biotech investments.
David Bonita
General Partner
OrbiMed
OrbiMed General Partner and physician-investor in healthcare and therapeutics.